Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | P4HB | P07237 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.70 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.70 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.63 |
| ▸ | XDH | P47989 | 1/20 | 0.60 |
| ▸ | KDM1A | O60341 | 1/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.58 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.58 |
| ▸ | TUBB | P07437 | 1/20 | 0.58 |
| ▸ | YES1 | P07947 | 1/20 | 0.58 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.58 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.58 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.58 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.58 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.58 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.58 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.58 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Liquiritin SCHEMBL13906116 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL13931703 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL29536850 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL24209243 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL15091079 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| Liquiritin SCHEMBL24835038 | 1.00 | TRPA1 (1.00) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL29351306 | 0.94 | TRPA1 (0.89) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL10926327 | 0.88 | TRPA1 (0.79) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL27939664 | 0.88 | TRPA1 (0.79) | TRPA1P4HBTRPV1PTPN1SLCO2B1 | |
| SCHEMBL31504735 | 0.88 | TRPA1 (0.79) | TRPA1P4HBTRPV1PTPN1SLCO2B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746852-A1 | LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION | Universität Bern (CH) | 2026-05-27 | — | — | EP | claimed |
| CN-122072266-A | Detection method of traditional Chinese medicine composition for treating lung heat cough and asthma | 贵州三力制药股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| CN-121570483-A | Application of liquiritin in preparing medicament for preventing/treating allergic asthma | 新疆维吾尔自治区药物研究院 | 2026-02-27 | — | — | CN | claimed |
| EP-3845065-B1 | BIPHENYL COMPOUND-CONTAINING LIQUID PREPARATION AND APPLICATION THEREOF | SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD (CN) | 2026-01-14 | — | — | EP | claimed |
| EP-3888670-B1 | DRUG FOR TREATING LEUKOPENIA, PREPARATION METHOD THEREFOR AND USE THEREOF | MONYAN PHARMACEUTICAL CO LTD (CN) | 2025-12-24 | — | — | EP | claimed |
| US-12446580-B2 | Liquid formulation of biphenyl-containing compound and application thereof | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2025-10-21 | — | — | US | claimed |
| US-12409192-B2 | Traditional Chinese medicine composition and use thereof | JIANGSU KANION PHARMACEUTICAL CO., LTD (CN) | 2025-09-09 | — | — | US | claimed |
| CN-120138149-A | Use of PTPRG as a marker for diagnosing colorectal cancer and as a therapeutic target | 宿州学院 | 2025-06-13 | — | — | CN | claimed |
| CN-120118997-A | MiRNA marker for diagnosing and treating colorectal cancer and application of miRNA marker in preparation of medicines for preventing and treating colorectal cancer | 宿州学院 | 2025-06-10 | — | — | CN | claimed |
| US-20250177467-A1 | COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS | UNIV YALE (US) | 2025-06-05 | — | — | US | claimed |
| CN-114097939-A | Sustained-release tablet matrix and preparation method and application thereof | 上海佩格医院管理有限公司 | 2022-03-01 | — | — | CN | claimed |
| CN-114088823-A | Method for measuring content of multi-index components in Tongtian oral liquid | 鉴甄检测技术（上海）有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-109856276-B | Content determination method of Qipi pills | 广西壮族自治区食品药品检验所 | 2022-02-25 | — | — | CN | claimed |
| CN-110873774-B | Method for establishing high performance liquid chromatography fingerprint spectrum of cough-relieving immediate effect pills | 山西华康药业股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-114034797-A | Method for measuring content of flower components of dendrobium nobile lindl | 遵义医科大学 | 2022-02-11 | — | — | CN | claimed |
| CN-114034798-A | Red water dendrobium stem flower fingerprint construction and content determination method | 遵义医科大学 | 2022-02-11 | — | — | CN | claimed |
| CN-111281944-B | Xiebai powder composition and preparation method and quality detection method thereof | 武汉同济现代医药科技股份有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-114002366-A | Large gentiana root decoction standard water extract, preparation and quality control evaluation method thereof | 京津冀联创药物研究（北京）有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-112641916-B | Traditional Chinese medicine ointment formula for building body and preparation method thereof | 辽宁上药好护士药业（集团）有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113956797-A | Jet polishing solution and polishing method for oxygen-free copper microstructure functional surface | 清华大学 | 2022-01-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12446580-B2 | Liquid formulation of biphenyl-containing compound and application thereof | ABCG2, CHIA, DDT | TRPA1 356/4885P4HB 3813/4885TRPV1 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.